Literature DB >> 29027045

Characteristics of patients with fragility hip fractures in the northern Kyushu district in Japan: a multicenter prospective registry based on an electronic data capture system.

Akiko Oyamada1, Yoshihiro Matsumoto2, Yoshifumi Wakata3, Atsushi Kimura1, Ko Ikuta4, Kuniyoshi Tsuchiya5, Naohisa Tayama6, Shinji Tomari7, Hisaaki Miyahara8, Takao Mae9, Hirokazu Shiraishi10, Taichi Saito11, Takeshi Arizono12, Kozo Kaji13, Taro Mawatari14, Masami Fujiwara15, Riku Sakimura16, Kunichika Shin17, Kenichi Ninomiya18, Kazutoshi Nakaie19, Yasuaki Antoku20, Shoji Tokunaga3, Naoki Nakashima3, Yukihide Iwamoto13, Yasuharu Nakashima1.   

Abstract

Osteoporosis has become a worldwide public health problem, in part due to the fact that it increases the risk of fragility hip fractures (FHFs). The epidemiological assessment of FHFs is critical for their prevention; however, datasets for FHFs in Japan remain scarce. This was a multicenter, prospective, observational study in the northern district of Kyushu Island. Inclusion criteria were age > 60 years with a diagnosis of FHF and acquisition of clinical data by an electronic data capture system. Of 1294 registered patients, 1146 enrolled in the study. Nearly one third of patients (31.8%) had a history of previous fragility fractures. The percentage of patients receiving osteoporosis treatment on admission was 21.5%. Almost all patients underwent surgical treatment (99.1%), though fewer than 30% had surgery within 48 h after hospitalization. Bone mineral density (BMD) was evaluated during hospitalization in only 50.4% of patients. The rate of osteoporosis treatment increased from 21.5% on admission to 39.3% during hospitalization. The main reasons that prescribers did not administer osteoporosis treatment during hospitalization were forgetfulness (28.4%) and clinical judgment (13.6%). Age and female ratio were significantly higher in patients with previous FHFs than in those without. There was a significant difference in the rate of osteoporosis treatment or L-spine BMD values in patients with or without previous FHFs on admission. In conclusion, this study confirmed that the evaluation and treatment of osteoporosis and FHFs is still suboptimal in Japan, even in urban districts.

Entities:  

Keywords:  Electronic data capture system; Fragility hip fracture; Multicenter prospective registry; Osteoporosis

Mesh:

Year:  2017        PMID: 29027045     DOI: 10.1007/s00774-017-0869-9

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  22 in total

1.  The risk of a second hip fracture in patients after their first hip fracture.

Authors:  Hiroshi Hagino; Takeshi Sawaguchi; Naoto Endo; Yasuyo Ito; Tetsuo Nakano; Yoshinobu Watanabe
Journal:  Calcif Tissue Int       Date:  2011-11-12       Impact factor: 4.333

Review 2.  Effect of early surgery after hip fracture on mortality and complications: systematic review and meta-analysis.

Authors:  Nicole Simunovic; P J Devereaux; Sheila Sprague; Gordon H Guyatt; Emil Schemitsch; Justin Debeer; Mohit Bhandari
Journal:  CMAJ       Date:  2010-09-13       Impact factor: 8.262

Review 3.  Electronic data capture for registries and clinical trials in orthopaedic surgery: open source versus commercial systems.

Authors:  Jatin Shah; Dimple Rajgor; Shreyasee Pradhan; Mariana McCready; Amrapali Zaveri; Ricardo Pietrobon
Journal:  Clin Orthop Relat Res       Date:  2010-10       Impact factor: 4.176

4.  Bilateral hip fractures.

Authors:  Tatsuki Fukushima; Akihiro Sudo; Atsumasa Uchida
Journal:  J Orthop Sci       Date:  2006-10       Impact factor: 1.601

5.  Underdiagnosis of vertebral fractures is a worldwide problem: the IMPACT study.

Authors:  Pierre D Delmas; Lex van de Langerijt; Nelson B Watts; Richard Eastell; Harry Genant; Andreas Grauer; David L Cahall
Journal:  J Bone Miner Res       Date:  2004-12-06       Impact factor: 6.741

6.  Ten-year risk of second hip fracture. A NOREPOS study.

Authors:  Tone K Omsland; Nina Emaus; Grethe S Tell; Luai A Ahmed; Jacqueline R Center; Nguyen D Nguyen; Clara G Gjesdal; Siri Forsmo; Berit Schei; Anne Johanne Søgaard; Haakon E Meyer
Journal:  Bone       Date:  2012-09-18       Impact factor: 4.398

7.  Recent trends in the incidence and lifetime risk of hip fracture in Tottori, Japan.

Authors:  H Hagino; K Furukawa; S Fujiwara; T Okano; H Katagiri; K Yamamoto; R Teshima
Journal:  Osteoporos Int       Date:  2008-07-17       Impact factor: 4.507

8.  Incidence of second hip fractures. A population-based study.

Authors:  E Lönnroos; H Kautiainen; P Karppi; S Hartikainen; I Kiviranta; R Sulkava
Journal:  Osteoporos Int       Date:  2007-04-18       Impact factor: 4.507

9.  Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence.

Authors:  C Roerholt; P Eiken; B Abrahamsen
Journal:  Osteoporos Int       Date:  2008-06-13       Impact factor: 4.507

10.  Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001.

Authors:  Jesper Ryg; Lars Rejnmark; Soren Overgaard; Kim Brixen; Peter Vestergaard
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

View more
  2 in total

1.  The association between CD31hiEmcnhi endothelial cells and bone mineral density in Chinese women.

Authors:  Yong Zhu; Zhe Ruan; Zhangyuan Lin; Haitao Long; Ruibo Zhao; Buhua Sun; Liang Cheng; Lanhua Tang; Zhuying Xia; Changjun Li; Shushan Zhao
Journal:  J Bone Miner Metab       Date:  2019-03-27       Impact factor: 2.626

2.  Factors affecting patient satisfaction related to cost and treatment effectiveness in rheumatoid arthritis: results from the multicenter observational cohort study, FRANK Registry.

Authors:  Toshifumi Fujiwara; Masakazu Kondo; Hisakata Yamada; Akihisa Haraguchi; Kenjiro Fujimura; Koji Sakuraba; Satoshi Kamura; Jun-Ichi Fukushi; Hisaaki Miyahara; Yasushi Inoue; Tomomi Tsuru; Toshihide Shuto; Seiji Yoshizawa; Eiichi Suematsu; Tomoya Miyamura; Masahiro Ayano; Hiroki Mitoma; Yojiro Arinobu; Hiroaki Niiro; Masanobu Ohishi; Akie Hirata; Shoji Tokunaga; Atsushi Takada; Daisuke Hara; Hidetoshi Tsushima; Yukio Akasaki; Satoshi Ikemura; Takuya Sueishi; Masakazu Toya; Takahide Sakuragi; Tomoko Tsutsui; Kazuhiro Kai; Shinkichi Arisumi; Yasuharu Nakashima
Journal:  Arthritis Res Ther       Date:  2022-02-22       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.